PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,791 | -5.8% | 15,409 | +30.1% | 0.00% | 0.0% |
| Q2 2023 | $169,635 | +100.7% | 11,846 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $84,538 | -35.1% | 11,840 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $130,197 | +7.6% | 11,604 | +6.1% | 0.00% | 0.0% |
| Q3 2022 | $121,000 | +33.0% | 10,933 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $91,000 | -33.6% | 10,778 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $137,000 | -35.4% | 10,055 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $212,000 | -40.4% | 10,763 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $356,000 | -7.3% | 11,085 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $384,000 | +51.8% | 11,348 | +68.2% | 0.00% | 0.0% |
| Q1 2021 | $253,000 | +22.2% | 6,747 | +8.0% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | -12.3% | 6,245 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $236,000 | +9.3% | 6,424 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $216,000 | +31.7% | 6,570 | +3.1% | 0.00% | 0.0% |
| Q1 2020 | $164,000 | -21.9% | 6,370 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $210,000 | – | 6,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |